GPIA Takes Firm Stance Against Required Pediatric Studies For Generics
This article was originally published in The Tan Sheet
Executive Summary
Generic drug sponsors bear no responsibility for pediatric studies for multisource drugs, the Generic Pharmaceutical Industry Association told FDA in March 3 comments on implementation of FDAMA pediatric exclusivity provisions and the agency's pediatric rule.